<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="several human diseases, including severe acute respiratory syndrome. The global" exact="coronavirus disease 2019" post="(COVID-19) pandemic has become a huge threat to humans."/>
 <result pre="the zoonotic severe acute respiratory syndrome coronavirus (SARS-CoV) and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) cause severe respiratory diseases and are associated"/>
 <result pre="In late 2019, a new infectious respiratory disease (now termed" exact="coronavirus disease 2019" post="[COVID-19]) emerged in Wuhan, China (Wang etÂ al., 2020a;"/>
 <result pre="substantial mortality rate (Chen etÂ al., 2020). ARDS during a" exact="SARS-CoV-2 infection" post="is also associated with dysregulation of cytokine production, barrier"/>
 <result pre="al., 2020; Mao etÂ al., 2020; Sultan etÂ al., 2020)." exact="SARS-CoV-2 infection" post="triggers an inflammatory response in the gut, as evidenced"/>
 <result pre="reduced expression and impaired function of this protein during a" exact="SARS-CoV infection" post="might substantially contribute to local disorders and pathogenesis. It"/>
 <result pre="modulate gastrointestinal disorders, including gut dysbiosis, in the context of" exact="SARS-CoV-2 infection." post="Along with inflammation and dysfunction of ACE2, other mechanisms"/>
 <result pre="that this may play a role in gastrointestinal disorders during" exact="SARS-CoV-2 infection." post="It is possible that the enteric nervous system could"/>
 <result pre="gut microbiota. Recent pilot studies suggest gut microbiota alterations during" exact="SARS-CoV-2 infection" post="(Yu etÂ al., 2020; Gu etÂ al., 2020b; Zuo"/>
 <result pre="that resiliency is long lasting (Zuo etÂ al., 2020). Hence," exact="SARS-CoV-2 infection" post="modifies the composition of the gut microbiota in humans."/>
 <result pre="after discovery to delineate the role of microbiome changes in" exact="SARS-CoV-2 infection" post="and post-infection recovery. It will be critical to consider"/>
 <result pre="and the comorbidity status of those patients. The consequences of" exact="SARS-CoV-2 infection" post="on the gut microbiota should also be investigated in"/>
 <result pre="of SCFA-promoting high-fiber diets and/or probiotics on the outcome of" exact="SARS-CoV-2 infection." post="Patients with respiratory infections generally have gut-dysfunction-related complications that"/>
 <result pre="in COVID-19 is still an open question. Evidence suggests that" exact="SARS-CoV-2 infection" post="alters the gut-blood barrier and thus leads to systemic"/>
 <result pre="al., 2020). This might affect the hostâ€™s initial response to" exact="SARS-CoV-2 infection" post="and might then contribute to multisystem dysfunction, septic shock,"/>
 <result pre="the systemic inflammation storm seen in the second phase of" exact="SARS-CoV-2 infection," post="which typically result in death (Guan etÂ al., 2020;"/>
 <result pre="changes in microbial profiles, and intestinal inflammation and leakiness during" exact="SARS-CoV infection" post="strongly amplify systemic pathways in comorbid individuals and exacerbate"/>
 <result pre="comorbid individuals and exacerbate underlying pathologies (e.g., diabetes and hypertension)." exact="SARS-CoV-2 infection" post="may also deteriorate the course of human inflammatory bowel"/>
 <result pre="diseases (Effenberger etÂ al., 2020). The mortality rate associated with" exact="SARS-CoV-2 infection" post="is higher in older adults, who also tend to"/>
 <result pre="be a therapeutic option. Concluding Remarks The complex pathogenesis of" exact="SARS-CoV-2 infection" post="is only starting to be deciphered. Along with the"/>
 <result pre="actively explored. In particular, several lines of evidence suggest that" exact="SARS-CoV-2 infection" post="is associated with alteration of the gut microbiota. It"/>
 <result pre="and moderate coronavirus disease 2019J.Â Clin. Invest.13020202620262932217835 CheungK.S.HungI.F.N.ChanP.P.Y.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.H.TamA.R.Gastrointestinal manifestations of" exact="SARS-CoV-2 infection" post="and virus load in fecal samples from a Hong"/>
 <result pre="by a clinically proven protease inhibitorCell1812020271280.e832142651 HonceR.Schultz-CherryS.Impact of obesity on" exact="Influenza" post="A Virus pathogenesis, immune response, and evolutionFront. Immunol.1020191071108431134099 HuangC.WangY.LiX.RenL.ZhaoJ.HuY.ZhangL.FanG.XuJ.GuX.Clinical"/>
 <result pre="Physiol.23420192277229530191985 ReddW.D.ZhouJ.C.HathornK.E.McCartyT.R.BazarbashiA.N.ThompsonC.C.ShenL.ChanW.W.Prevalence and characteristics of gastrointestinal symptoms in patients with" exact="SARS-CoV-2 infection" post="in the United States: A multicenter cohort studyGastroenterology202010.1053/j.gastro.2020.04.045Published online"/>
 <result pre="with COVID-19Gastroenterology202010.1053/j.gastro.2020.05.001Published online May 11, 2020 SunS.-H.ChenQ.GuH.-J.YangG.WangY.-X.HuangX.-Y.LiuS.-S.ZhangN.-N.LiX.-F.XiongR.A mouse model of" exact="SARS-CoV-2 infection" post="and pathogenesisCell Host Microbe202010.1016/j.chom.2020.05.020Published online May 27, 2020 SungnakW.HuangN.BÃ©cavinC.BergM.QueenR.LitvinukovaM.Talavera-LÃ³pezC.MaatzH.ReichartD.SampaziotisF.collab:"/>
 <result pre="in Wuhan, ChinaJAMA323202010611069 WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="Coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
 <result pre="subtype of coronavirus disease 2019medRxiv202010.1101/2020.03.03.20030650 ZangR.Gomez CastroM.F.McCuneB.T.ZengQ.RothlaufP.W.SonnekN.M.LiuZ.BruloisK.F.WangX.GreenbergH.B.TMPRSS2 and TMPRSS4 promote" exact="SARS-CoV-2 infection" post="of human small intestinal enterocytesSci. Immunol.52020eabc358232404436 ZhangW.DuR.H.LiB.ZhengX.S.YangX.L.HuB.WangY.Y.XiaoG.F.YanB.ShiZ.L.ZhouP.Molecular and serological"/>
</results>
